Drug-Eluting Stent Panelists Could Not Agree On Definition Of Thrombosis
This article was originally published in The Gray Sheet
Executive Summary
FDA advisory panel members examining the risks of thrombosis in on- and off-label use of drug-eluting stents earlier this month could not reach a consensus on which definition of thrombosis to use